Enveric Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -84 | -85 | ||
EBITDA | -3,091 | -1,998 | -1,813 | -2,391 |
EBIT | -3,173 | -2,083 | -1,897 | -2,477 |
Net Income | -3,154 | -2,084 | -1,879 | -2,456 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,311 | -927 | -2,889 | -2,598 |
Cash | 2,241 | 3,111 | 3,502 | 6,356 |
Basic Shares | 1,330 | 8,702 | 7,587 | 4,001 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -408 | -435 | -681 | |
EBITDA | -9,246 | -16,854 | -19,634 | -63,966 |
EBIT | -9,583 | -17,262 | -20,069 | -64,648 |
Net Income | -9,574 | -17 | -18,471 | -48,976 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,726 | -14,099 | -17,730 | -12,322 |
Cash | 2,241 | 2,287 | 17,723 | 17,355 |
Basic Shares | 502 | 2,159 | 1,446 | 472 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$4.81 |
2024-12-31 | -$0.16 |
2024-09-30 | -$0.23 |
2024-06-30 | -$0.25 |
